Berking, Carola

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study.

Ascierto, P. A., Schadendorf, D., Berking, C., Agarwala, S. S., van Herpen, C. M., Queirolo, P., Blank, C. U., Hauschild, A., Beck, J. T., St-Pierre, A., et al. (2013) · The Lancet Oncology

Melanoma and MAPK PathwaysCutaneous Melanoma Detection and Management

Cited by 640

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Weide, B., Martens, A., Hassel, J. C., Berking, C., Postow, M. A., Bisschop, K., Simeone, E., Mangana, J., Schilling, B., Di Giacomo, A. M., et al. (2016) · Clinical Cancer Research

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 589

Deep neural networks are superior to dermatologists in melanoma image classification

Brinker, T. J., Hekler, A., Enk, A. H., Berking, C., Haferkamp, S., Hauschild, A., Weichenthal, M., Klode, J., Schadendorf, D., Holland-Letz, T., et al. (2019) · European Journal of Cancer

Cutaneous Melanoma Detection and ManagementAI in cancer detection

Cited by 415

5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma

Poeck, H., Besch, R., Maihoefer, C., Renn, M., Tormo, D., Morskaya, S. S., Kirschnek, S., Gaffal, E., Landsberg, J., Hellmuth, J., et al. (2008) · Nature Medicine

RNA Interference and Gene Deliveryinterferon and immune responses

Cited by 387

Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts

Haggenmüller, S., Maron, R. C., Hekler, A., Utikal, J. S., Barata, C., Barnhill, R. L., Beltraminelli, H., Berking, C., Betz-Stablein, B., Blum, A., et al. (2021) · European Journal of Cancer

Cutaneous Melanoma Detection and ManagementAI in cancer detection

Cited by 267

Pathologist-level classification of histopathological melanoma images with deep neural networks

Hekler, A., Utikal, J. S., Enk, A. H., Berking, C., Klode, J., Schadendorf, D., Jansen, P., Franklin, C., Holland-Letz, T., Krahl, D., et al. (2019) · European Journal of Cancer

AI in cancer detectionCutaneous Melanoma Detection and Management

Cited by 231

Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark

Brinker, T. J., Hekler, A., Hauschild, A., Berking, C., Schilling, B., Enk, A. H., Haferkamp, S., Karoglan, A., von Kalle, C., Weichenthal, M., et al. (2019) · European Journal of Cancer

Cutaneous Melanoma Detection and ManagementAI in cancer detection

Cited by 157

Accuracy of a smartphone application using fractal image analysis of pigmented moles compared to clinical diagnosis and histological result

Maier, T., Kulichova, D., Schotten, K., Astrid, R., Ruzicka, T., Berking, C., & Udrea, A. (2015) · Journal of the European Academy of Dermatology and Venereology

Cutaneous Melanoma Detection and ManagementAI in cancer detection

Cited by 103

Clonality of CD4+ Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma

Arakawa, A., Vollmer, S., Tietze, J., Galinski, A., Heppt, M. V., Bürdek, M., Berking, C., & Prinz, J. C. (2019) · Frontiers in Immunology

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 74

Effects of Label Noise on Deep Learning-Based Skin Cancer Classification

Hekler, A., Kather, J. N., Krieghoff-Henning, E., Utikal, J. S., Meier, F., Gellrich, F. F., Upmeier zu Belzen, J., French, L., Schlager, J. G., Ghoreschi, K., et al. (2020) · Frontiers in Medicine

Cutaneous Melanoma Detection and ManagementAI in cancer detection

Cited by 58

Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology: Actinic keratosis in high-definition optical coherence tomography

Maier, T., Braun-Falco, M., Laubender, R. P., Ruzicka, T., & Berking, C. (2013) · British Journal of Dermatology

Nonmelanoma Skin Cancer StudiesOptical Coherence Tomography Applications

Cited by 57

Inhibition of histone deacetylases in melanoma—a perspective from bench to bedside

Hornig, E., Heppt, M. V., Graf, S. A., Ruzicka, T., & Berking, C. (2016) · Experimental Dermatology

Histone Deacetylase Inhibitors ResearchMelanoma and MAPK Pathways

Cited by 50